494 related articles for article (PubMed ID: 1462825)
1. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
Jones TH; Figueroa CD; Smith CM; Bhoola KD
Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
[TBL] [Abstract][Full Text] [Related]
2. Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas.
Jones TH; Figueroa CD; Smith CM; Cullen DR; Bhoola KD
J Endocrinol; 1992 Jul; 134(1):149-54. PubMed ID: 1500840
[TBL] [Abstract][Full Text] [Related]
3. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
Ma W; Ikeda H; Yoshimoto T
Cancer; 2002 Jul; 95(2):258-66. PubMed ID: 12124824
[TBL] [Abstract][Full Text] [Related]
5. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
Schatz H; Stracke H; Hildebrandt G
Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
[TBL] [Abstract][Full Text] [Related]
6. Prolactin secretion after surgery or bromocriptine treatment of prolactinoma.
De Leo V; Petraglia F; Sardelli S; Danero S; Genazzani AR; D'Antona N
Obstet Gynecol; 1987 Jan; 69(1):99-103. PubMed ID: 3099236
[TBL] [Abstract][Full Text] [Related]
7. Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists.
Hamester U; Saeger W; Lüdecke DK
Histol Histopathol; 1987 Apr; 2(2):135-42. PubMed ID: 2980713
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard.
Lundberg PO; Bergström K; Thuomas KA; Muhr C; Enoksson P
Acta Radiol Suppl; 1986; 369():310-3. PubMed ID: 2980483
[TBL] [Abstract][Full Text] [Related]
9. [Medical treatment of prolactin-secreting pituitary adenomas. Influence of the size of the adenoma].
Kuhn JM; Gancel A; Weinstein A; Courtois H; Schrub JC; Tadie M; Wolf LM
Presse Med; 1985 Mar; 14(9):525-8. PubMed ID: 3157164
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine.
Yin D; Kondo S; Takeuchi J; Morimura T
Oncol Res; 1993; 5(9):383-7. PubMed ID: 8038459
[TBL] [Abstract][Full Text] [Related]
11. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
[No Abstract] [Full Text] [Related]
12. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
Nishioka H; Haraoka J; Akada K
Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J
Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
[TBL] [Abstract][Full Text] [Related]
15. Human prolactin-producing adenomas and bromocriptine: a histological, immunocytochemical, ultrastructural, and morphometric study.
Tindall GT; Kovacs K; Horvath E; Thorner MO
J Clin Endocrinol Metab; 1982 Dec; 55(6):1178-83. PubMed ID: 6752167
[No Abstract] [Full Text] [Related]
16. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
Esiri MM; Bevan JS; Burke CW; Adams CB
J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
Peillon F; Cesselin F; Bression D; Zygelman N; Brandi AM; Nousbaum A; Mauborgne A
J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
[TBL] [Abstract][Full Text] [Related]
18. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
Lamberts SW; de Quijada M; Klijn JG
J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome.
Hubbard JL; Scheithauer BW; Abboud CF; Laws ER
J Neurosurg; 1987 Dec; 67(6):816-21. PubMed ID: 3681421
[TBL] [Abstract][Full Text] [Related]
20. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]